Stock & Company Details
Denali Therapeutics Inc $DNLI
Price:
N/A
N/A
160M
$3B
52 Week High:
N/A
10 Day Average Volume:
N/A
-6.58
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
DNLI technical indicators
Latest Denali Therapeutics Inc (DNLI) indicator readings as of 2026-10-09.
DNLI's 14-day RSI is 37.8, in neutral territory. At $19.45 it is trading 7.9% below its 200-day moving average of $21.11, and below its 50-day average of $22.41. Price sits in the middle of its Bollinger Bands ($18.82 to $21.62). ADX reads 27.7, indicating a trending market.
Overview
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.
Finance Bot
Ask your questions
Start by typing a question below.
